Table 6

Main and secondary outcomes for website groups at twelve week follow up
Variable Website Website + support No website group Significance
IBS-SSS total mean (n = 123) 207.9 (187.6 – 228.1) 193.4 (173.0- 213.8) 218.2 (197.4-238.9) p = 0.243
IBS-QOL score (n = 123) 71.6 (67.2 - 76.1) 69.5 (65.0 - 74.0) 64.3 (59.8 – 68.9) p = 0.068
HADS score for anxiety (n = 114) 8.8 (8.0- 9.7) 9.2 (8.3 -10.0) 8.0 (7.1 -8.8) p = 0.123
HADS score for depression (n = 114) (%) p = 0.981
Normal (0–7) 32 (84.2) 31 (79.5) 30 (81.1)
Mild (8–10) 6 (15.8) 4 (10.3) 4 (10.8)
Moderate or Severe (11–21) 0 (0) 4 (10.3) 3 (8.1)
Enablement score (n = 113) (%) p = 0.000**
0 7 (18.4) 4 (10.5) 21 (56.8)
1-2 7 (18.4) 5 (13.2) 4 (10.8)
3-5 13 (34.2) 15 (39.5) 7 (18.9)
6-12 11 (28.9) 14 (36.8) 5 (13.5)
SGA (%)
Responders 16 (45.7) 24 (63.2) 12 (32.4) p = 0.035*
Non responders 19 (54.3) 14 (36.8) 25 (67.6)

Analysis of the 12 week follow-up scores.

ANCOVA for IBS SSS, IBS-QOL and HADs Anxiety, Mean (95% CI). Ordinal Regression for HADs Depression, Enablement and SGA (n (%).

Everitt et al.

Everitt et al. BMC Gastroenterology 2013 13:68   doi:10.1186/1471-230X-13-68

Open Data